Concepedia

Kun Hu

KH

Statistics

Publications

5

Citations

227

H-Index

5

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kun Hu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in molecular oncology, pharmacology, and oncology.

Publications per year

2006–2019

5

Publications

5

Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2

Hua‐Quan Miao, Kun Hu, Xenia Jimenez et al. · Biochemical and Biophysical Research Communications · 2006 · 89 citations

, , +12

A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit

Johnny E. Kopinja, Raquel Sevilla, Diane Levitan et al. · Scientific Reports · 2017 · 52 citations · Full text

, , +9

MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer

Youjin Lu, Rong‐Yu Liu, Kun Hu et al. · Tumor Biology · 2016 · 42 citations

, , +17

PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models

Katharine Ellwood‐Yen, Heike Keilhack, Kaiko Kunii et al. · Cancer Research · 2011 · 32 citations

, , +17

Exploring Pharmacological Mechanisms of Xiang Ju Tablets in the Treatment of Allergic Rhinitis via a Network Pharmacology Approach

Kun Hu, Xi Duan, Li zhu Han et al. · Evidence-based Complementary and Alternative Medicine · 2019 · 12 citations · Full text

, , +17

1–5 of 5